Genetically modified lymphocytes

autologous genetically modified T cells · National Institute of Allergy and Infectious Diseases (NIAID)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Genetically modified lymphocytes, covering 2008-03-04 to 2008-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Genetically Modified Lymphocytes to Treat HIV-Infected Identical Twins - Study Modifications [Phase 1]